Lung nodules

ADULT
  • If any of the following are present or suspected, please refer the patient to the emergency department (via ambulance if necessary) or follow local emergency care protocols or seek emergent medical advice if in a remote region.

    • No emergency indicators identified; routine prioritisation applies
  • Request for advice

    Available to GPs who use GPSR and available at your local Health Service

    • Lung nodule(s) identified where:
      • The GP requires further management advice
      • Guidance is not available on HealthPathways
      • The case does not clearly fit into any other referral categories
      • Guidance is required in specific patient groups, such as the follow up of small pulmonary nodules (<6mm) in patients with a personal history of cancer.

    Other Useful Information

    Type Risk2<6mm6-8mm (≥6 for subsolid)
    SolidSingleLowNone6-12 months then consider at 18-24 months
    High12 months (optional)6-12 months then at 18-24 months
    MultipleLowNone3-6 months then consider at 18-24 months
    High12 months (Optional)3-6 months then at 18-24 months
    Non-solid No routine follow-up6-12 months then 2-yearly for 5 yrs
    Part-solid No routine follow-up3-6 months then yearly for 5 yrs
    Multiple 3-6 months then annual for 5 years3-6 months then based on most suspicious

      1Not intended for patients <35 years, lung cancer screening, history of cancer or immunocompromised
      2High-risk factors include older age, heavy smoking, irregular or spiculated margins, and upper lobe location
      .

    • Nodules that do not require referral include:
      • Nodules with diffuse, central, laminated or popcorn patterns of calcification or macroscopic fat
      • Juxtapleural (perifissural) nodules with characteristic triangular morphology < 10 mm diameter
      • Solid nodules stable for at least 2 years
      • Non-solid, part solid and atypical pulmonary cysts stable for at least 5 years
    • Review of previous imaging is very important to determine if nodules are new, enlarging, stable or decreased.
    • Follow up imaging of nodules should be performed at the same radiology service and on the same equipment, if possible.
Minimum Referral Criteria
Category 1
(appointment within 30 calendar days)
Lung nodules are traditionally defined as ≤30 mm in diameter.  This section is relevant to both screening detected and incidental (scan performed for a different reason) lung nodules.

Any one of the following:

SolidPart SolidNon-solid (Ground glass)
National Lung Cancer Screening Program
  • High Risk (Cat 5) or Very High Risk (Cat 6) nodules
  • Calculated risk of malignancy >30%
Nodule Size1>8mmSolid component >8mm 
Nodule volume 2≥268 mm3Solid component ≥268 mm3 
Change from previous scans (within 24 months)
  • Progressive growth over 3 or more scans
  • Increase in size of >1.5 mm or volume of >25%
  • Progressive growth over 3 or more scans
  • Solid component ≥4 mm or ≥34 mm3 which is new or growing
  • Doubling in size within 12 months
Other features
  • Growing nodule within a larger airway (segmental or more proximal)
  • Progressive atypical cyst compared to previous scan(s)
  • Regional lymphadenopathy
  • Frank metastatic disease with no other obvious source

(1) Dimensions are average of long and short axes, rounded to the nearest millimetre.  Where only the largest diameter is provided in the imaging Report, this measurement can be considered
(2) Volume calculated from radiology volumetric software.

Category 2
(appointment within 90 calendar days)

Any one of the following:

SolidPart SolidNon-solid (Ground glass)
National Lung Cancer Screening Program
  • Moderate Risk (Cat 4) nodules where community follow up is not possible or where additional clinical risk factors are present.
Nodule Size16-8 mmSolid component 6-8 mm≥30 mm
Nodule volume 2≥113 to <268 mm3Solid component 113 to <268 mm3 
Change from previous scans (within 24 months)Nodule 4 to <8 mm (113 to <268 mm3) which is new or growingSolid component of nodule <4 mm (<34 mm3) which is new or growing
  • Doubling in size within 12 months
Other features
  • Nodule within a larger airway (segmental or more proximal)
  • Atypical pulmonary cyst (multilocular or thick walled)
  • Personal history of cancer - Request for Advice is available, if required, for small nodules that do not meet standard criteria.

(1) Dimensions are average of long and short axes, rounded to the nearest millimeter.  Where only the largest diameter is provided in the imaging Report, this measurement can be considered as a surrogate for the average.
(2) Volume calculated from radiology volumetric software.

Category 3
(appointment within 365 calendar days)
  • There are no Category 3 criteria. Support for managing nodules <6 mm (that do not meet criteria for change from previous scans above) can be obtained by Request for Advice, if required.

Please insert the below information and minimum referral criteria into referral

1. Reason for request Indicate on the referral

  • To establish a diagnosis
  • For treatment or intervention
  • For advice and management
  • For specialist to take over management
  • Reassurance for GP/second opinion
  • For a specified test/investigation the GP can't order, or the patient can't afford or access
  • Reassurance for the patient/family
  • For other reason (e.g. rapidly accelerating disease progression)
  • Clinical judgement indicates a referral for specialist review is necessary

2. Essential referral information Referral will be returned without this

  • Chest imaging and details of radiology provider
  • Details and pathology results (if available) of previous malignancies
  • NLCSP screening report, if applicable
  • Patient characteristics which influence risk of malignancy:
    • Personal history of cancers
    • Patient history, symptoms, and indication for CT (if CT performed for respiratory (infective) symptoms, consider short interval repeat CT depending on radiological likelihood of malignancy (e.g., 8–12 weeks)
    • Detailed smoking history including tobacco, marijuana, electronic cigarettes, and illicit drugs
    • Family history of lung cancer
    • Ethnicity
    • Occupational exposures
    • Known underlying lung disease, for example, COPD, Interstitial lung disease
    • Medications, for example, anticoagulation, immunosuppressive drugs

3. Additional referral information Useful for processing the referral

  • Historical imaging (if available)
  • FBC, ELFT and any other relevant pathology results

4. Request

  • Patient's Demographic Details

    • Full name (including aliases)
    • Date of birth
    • Residential and postal address
    • Telephone contact number/s – home, mobile and alternative
    • Medicare number (where eligible)
    • Name of the parent or caregiver (if appropriate)
    • Preferred language and interpreter requirements
    • Identifies as Aboriginal and/or Torres Strait Islander

    Referring Practitioner Details

    • Full name
    • Full address
    • Contact details – telephone, fax, email
    • Provider number
    • Date of referral
    • Signature

    Relevant clinical information about the condition

    • Presenting symptoms (evolution and duration)
    • Physical findings
    • Details of previous treatment (including systemic and topical medications prescribed) including the course and outcome of the treatment
    • Body mass index (BMI)
    • Details of any associated medical conditions which may affect the condition or its treatment (e.g. diabetes), noting these must be stable and controlled prior to referral
    • Current medications and dosages
    • Drug allergies
    • Alcohol, tobacco and other drugs use

    Reason for request

    • To establish a diagnosis
    • For treatment or intervention
    • For advice and management
    • For specialist to take over management
    • Reassurance for GP/second opinion
    • For a specified test/investigation the GP can't order, or the patient can't afford or access
    • Reassurance for the patient/family
    • For other reason (e.g. rapidly accelerating disease progression)
    • Clinical judgement indicates a referral for specialist review is necessary

    Clinical modifiers

    • Impact on employment
    • Impact on education
    • Impact on home
    • Impact on activities of daily living
    • Impact on ability to care for others
    • Impact on personal frailty or safety
    • Identifies as Aboriginal and/or Torres Strait Islander

    Other relevant information

    • Willingness to have surgery (where surgery is a likely intervention)
    • Choice to be treated as a public or private patient
    • Compensable status (e.g. DVA, Work Cover, Motor Vehicle Insurance, etc.)
  • If any of the following are present or suspected, please refer the patient to the emergency department (via ambulance if necessary) or follow local emergency care protocols or seek emergent medical advice if in a remote region.

    • Please note that where appropriate and where available, the referral may be streamed to an associated public allied health and/or nursing service.  Access to some specific services may include initial assessment and management by associated public allied health and/or nursing, which may either facilitate or negate the need to see the public medical specialist.
    • A change in patient circumstance (such as condition deteriorating or becoming pregnant) may affect the urgency categorisation and should be communicated as soon as possible.
    • Please indicate in the referral if the patient is unable to access mandatory tests or investigations as they incur a cost or are unavailable locally.

Last updated: 3 July 2025

© State of Queensland (Queensland Health) 2023

Except as permitted under the Copyright Act 1968, no part of this work may be reproduced, communicated or adapted without permission from Queensland Health. To request permission email ip_officer@health.qld.gov.au1.